Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
L3Harris
LHX
|
+$148M |
| 2 |
GE HealthCare
GEHC
|
+$118M |
| 3 |
Atlassian
TEAM
|
+$101M |
| 4 |
Axon Enterprise
AXON
|
+$23.7M |
| 5 |
Reliance Steel & Aluminium
RS
|
+$22.4M |
Top Sells
| 1 |
Apple
AAPL
|
+$360M |
| 2 |
Microsoft
MSFT
|
+$199M |
| 3 |
GE Aerospace
GE
|
+$131M |
| 4 |
NVIDIA
NVDA
|
+$99.2M |
| 5 |
Amazon
AMZN
|
+$85.4M |
Sector Composition
| 1 | Technology | 28.64% |
| 2 | Healthcare | 14.81% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Industrials | 9.44% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Maximus
MMS
$5.08B
| $10.3M | 0.01% |
131,207
-15,000
| -10% | -$1.18M |
|
852
DT Midstream
DTM
$10.9B
| $10.3M | 0.01% |
208,800
-24,800
| -11% | -$1.22M |
|
853
Post Holdings
POST
$5.76B
| $10.2M | 0.01% |
113,900
-16,000
| -12% | -$1.44M |
|
854
United Bankshares
UBSI
$5.4B
| $10.2M | 0.01% |
290,663
-34,300
| -11% | -$1.21M |
|
855
Macy's
M
$4.67B
| $10.2M | 0.01% |
584,900
-69,500
| -11% | -$1.22M |
|
856
Workiva
WK
$4.39B
| $10.2M | 0.01% |
99,821
-11,300
| -10% | -$1.16M |
|
857
Silgan Holdings
SLGN
$4.76B
| $10.2M | 0.01% |
190,100
-22,800
| -11% | -$1.22M |
|
858
Ryman Hospitality Properties
RHP
$6.35B
| $10.1M | 0.01% |
113,100
-13,500
| -11% | -$1.21M |
|
859
Medpace
MEDP
$14B
| $10.1M | 0.01% |
53,700
-6,200
| -10% | -$1.17M |
|
860
Simpson Manufacturing
SSD
$8.07B
| $10.1M | 0.01% |
92,000
-12,200
| -12% | -$1.34M |
|
861
Glacier Bancorp
GBCI
$5.8B
| $10M | 0.01% |
239,021
-28,400
| -11% | -$1.19M |
|
862
Alkermes
ALKS
$4.57B
| $10M | 0.01% |
354,700
-41,900
| -11% | -$1.18M |
|
|
NEWR
863
DELISTED
New Relic, Inc.
NEWR
| $10M | 0.01% |
132,797
-13,500
| -9% | -$1.02M |
|
864
Option Care Health
OPCH
$4.77B
| $9.98M | 0.01% |
314,000
-37,300
| -11% | -$1.19M |
|
865
RH
RH
$4.27B
| $9.97M | 0.01% |
40,930
-6,700
| -14% | -$1.63M |
|
866
Brookfield Infrastructure
BIPC
$4.83B
| $9.96M | 0.01% |
216,477
-24,700
| -10% | -$1.14M |
|
|
ITCI
867
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $9.96M | 0.01% |
183,900
-21,300
| -10% | -$1.15M |
|
868
PENN Entertainment
PENN
$2.92B
| $9.93M | 0.01% |
334,884
-48,000
| -13% | -$1.42M |
|
869
BellRing Brands
BRBR
$4.7B
| $9.93M | 0.01% |
292,024
-36,900
| -11% | -$1.25M |
|
870
Watts Water Technologies
WTS
$9.47B
| $9.91M | 0.01% |
58,900
-7,000
| -11% | -$1.18M |
|
871
Vertiv
VRT
$51.8B
| $9.91M | 0.01% |
692,200
-81,600
| -11% | -$1.17M |
|
872
Kite Realty
KRG
$5B
| $9.89M | 0.01% |
472,897
-56,200
| -11% | -$1.18M |
|
873
Hanover Insurance
THG
$6.51B
| $9.87M | 0.01% |
76,800
-9,200
| -11% | -$1.18M |
|
874
Ionis Pharmaceuticals
IONS
$10.2B
| $9.86M | 0.01% |
275,900
-32,500
| -11% | -$1.16M |
|
875
Chemours
CC
$2.51B
| $9.75M | 0.01% |
325,700
-48,900
| -13% | -$1.46M |
|